Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Health Econ. 2017 Mar 22;54:25–39. doi: 10.1016/j.jhealeco.2017.03.005

Table A4.

30-Day Readmission Outcomes: First Stage, OLS and 2SLS Estimates, by Risk-Standardized 90D Hospital Spending Measure

90D Inpatient Spending
90D Non-Inpatient Spending
(1) (2) (3) (4)
Panel A. First Stage
Ambulance Average 90D Inpatient Spending 0.250
(0.0052)
0.251
(0.0052)
Ambulance Average 90D Non-Inpatient Spending 0.136
(0.0045)
0.137
(0.0045)
Panel B. OLS
90D Inpatient Spending 0.002
(0.0016)
−0.003
(0.0015)
90D Non-Inpatient Spending 0.003
(0.0017)
0.002
(0.0016)
Panel C. 2SLS
90D Inpatient Spending −0.021
(0.0063)
−0.030
(0.0063)
90D Non-Inpatient Spending 0.021
(0.0092)
0.009
(0.0090)
Sample Size 1,575,273
Outcome Mean 0.426
Patient Controls No Yes No Yes

Notes: Each column reports model results based on hospital measures of total spending over 90 days after the index admission. All spending measures are trimmed of outliers and then risk-standardized by age, race and gender. Risk-standardized spending measures have been demeaned and scaled by 2 standard deviations. Thus, the reported coefficients reflect a difference of ±1 standard deviations from the mean (i.e., “low” vs. “high” spending). Means (SDs) for spending variables: 90D Inpatient Total = $15,876 (3,113); 90D Non-Inpatient Total = $10,557 (1,585). Models without patient controls include ZIP × patient origin fixed effects, as well as year and principal diagnosis controls (see Table A1 for a full list); models with patient controls adds all patient and ambulance controls as listed in Table 1, with age controls in 5-year bins. Standard errors, clustered at the Health Service Area (HSA) level, are reported in parentheses.

Source: 2002–2012 Medicare Part A and B Data